Word: gao
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...diverted from their intended purposes. There were solid grounds for that concern. The General Accounting Office, an investigative arm of Congress, reported last week that the State Department was unable to account definitively for some $17 million of the $27 million that Congress had authorized for the program. The GAO claimed that a small amount was actually spent on military equipment; an Administration source confirmed this but blamed a mistake by a contractor. In another example of undocumented spending, diplomats familiar with the project say that $900,000 had been paid indirectly to officials in Honduras as bribes...
...Emperor's Shadow covers some 30 years in the lives of two boys: a sturdy kid who will become the Emperor and his sensitive friend who will become the musician Gao Jianli ? think Jimmy Cagney and Pat O'Brien in Angels With Dirty Faces. Both are suckled by Jianli's mother and raised as brothers. When they're 10, they're separated for pursue their different and colliding destinies. In maturity, the warlord (played with a bull-headed majesty by Jiang Wen, China's leading movie actor) hears than Jianli (Ge You, a stalwart of several Zhang Yimou films...
...pull; their lyrics don't put the personal conflicts across with the same clarity and intensity. Domingo, a trouper at 64, has the notes down but struggles with his enunciation. (Even though he's singing in English, we needed the subtitles.) Paul Groves gets all he can out of Gao Jianli, but the role as written here hasn't nearly the force of will, the sacred venom, that Ge You embodied in the film. Best among the principals is Elizabeth Futral as Yueyang: at once coquettish and ferocious, adroitly meeting the role's singing and acting requirements...
...business interests have actually been a factor in curbing innovations, the GAO found. During the past decade the pharmaceutical industry has tended to focus on "blockbuster drugs" for large patient populations that can generate as much as $1 billion in annual sales, while ignoring "other drugs for more limited populations that generate much less revenue." Manufacturers find "me too" drug development less risky and more potentially lucrative than research into brand-new medications. Drug company mergers in the early 1990s also have resulted in the larger firms' scaling back R&D into new drugs as they look to cut costs...
...GAO had the National Academy of Sciences convene a panel of 14 doctors, scientists, pharmaceutical industry researchers and patient advocates to come up with ways to spur innovation. They recommended more collaboration among government, industry and academia. Colleges, for example, could offer more scholarships to train translational researchers. The government could offer more incentives for innovative drug research. Patents for breakthrough drugs could be extended from the current 20 years to 25-30 years, while patents for "me too" drugs could be shortened to 10 years. Otherwise the billions for research will end up producing bigger profits, but not necessarily...